Impact of dermatologic adverse events induced by targeted therapies on quality of life. Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S.. Crit Rev Oncol Hematol. 2016; 158-68: p.158-68. doi:10.1016/j.critrevonc.2016.03.003 10.1016/j.critrevonc.2016.03.003. Epub 2016 Mar 5.Article
Suivi gynécologique, médecin impliqué et dépistage du cancer du col utérin : une accumulation de disparités sociales. Malmartel, A.; Rigal, Laurent. Journal de Gynecologie obstétrique et biologie de la reproduction. 2016; 459-466: p.459-466Article
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Ma, X.; Le Teuff, G.; Lacas, B.; Tsao, M. S.; Graziano, S.; Pignon, J. P.; Douillard, J. Y.; Le Chevalier, T.; Seymour, L.; Filipits, M.; Pirker, R.; Janne, P. A.; Shepherd, F. A.; Brambilla, E.; Soria, J. C.; Hainaut, P.; Group, L. A. C. E. Bio Collaborative. J Thorac Oncol. 2016; 850-61: p.850-61. doi:10.1016/j.jtho.2016.02.002 10.1016/j.jtho.2016.02.002. Epub 2016 Feb 17.Article
The Discrepancy between Performance-Based Measures and Questionnaires when Assessing Clinical Outcomes and Quality of Life in Pediatric Patients with Neurological Disorders. Coutinho, V.; Câmara-Costa, H.; Kemlin, I.; Billette de Villemeur, T.; Rodriguez, D.; Dellatolas, G.. Applied Neuropsychology. Child. 2016; 1-7: p.1-7. doi:10.1080/21622965.2016.1146141Article
Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by. Scarabin, P. Y.; Canonico, M.; Scarabin-Carre, V.; Oger, E.. J Clin Endocrinol Metab.. 2016; L30-1: p.L30-1Article
Predictive factors of dropout from inpatient treatment for anorexia nervosa. Roux, H.; Ali, A.; Lambert, S.; Radon, L.; Huas, C.; Curt, F.; Berthoz, S.; Godart, Nathalie; EVHAN Group. BMC psychiatry. 2016; 339: p.339. doi:10.1186/s12888-016-1010-7Article
[Changes in mineral and bone disorder management in a French cohort of hemodialysis patients between 2008 and 2012: The National Bone and Mineral Metabolism observatory (Photo-Graphe 2 and 3)]. Pelletier, Solenne; Roth, Hubert; Bouchet, Jean-Louis; Drüeke, Tilman B.; Hannedouche, Thierry; Jean, Guillaume; London, Gérard; Fouque, Denis; les investigateurs de l’observatoire Photo-Graphe 3. Nephrologie & Therapeutique. 2016; : . doi:10.1016/j.nephro.2015.11.005Article
Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research. Blanchard, P.; Garden, A. S.. J Clin Oncol. 2016; 2317-8: p.2317-8. doi:10.1200/JCO.2015.66.0894 10.1200/JCO.2015.66.0894. Epub 2016 Apr 25.Article
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer. Gouy, S.; Ferron, G.; Glehen, O.; Bayar, A.; Marchal, F.; Pomel, C.; Quenet, F.; Bereder, J. M.; Le Deley, M. C.; Morice, P.. Gynecol Oncol. 2016; 237-42: p.237-42. doi:10.1016/j.ygyno.2016.05.032 10.1016/j.ygyno.2016.05.032. Epub 2016 Jun 2.Article
Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution. Proust-Houdemont, S.; Pasqualini, C.; Blanchard, P.; Dufour, C.; Benhamou, E.; Goma, G.; Semeraro, M.; Raquin, M. A.; Hartmann, O.; Valteau-Couanet, D.. Bone Marrow Transplant. 2016; 1076-81: p.1076-81. doi:10.1038/bmt.2016.75 10.1038/bmt.2016.75. Epub 2016 Apr 4.Article